Clinical trial
Chromium Picolinate for the Treatment of Metabolic Syndrome
NCT00128154 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00128154 |
|---|---|
| Title | Chromium Picolinate for the Treatment of Metabolic Syndrome |
| Official title | A Double-Blind Randomized Controlled Clinical Trial of Chromium Picolinate on Clinical and Biochemical Features of the Metabolic Syndrome |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Metabolic Syndrome X, Prediabetic State, Insulin Resistance, Obesity, Metabolic Diseases |
| Intervention type | Drug |
| Interventions | Chromium picolinate |
| Enrollment | 60 |
| Start date | Jan 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Aug 9, 2005 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: